• Mashup Score: 0

    The Bristol Myers Squibb–Pfizer Alliance, with the support of leading advocacy organisations (such as AF Association) and medical societies, has launched a new US campaign — No Time To Wait — to raise awareness of three important conditions: Atrial Fibrillation (AF), deep vein thrombosis (DVT), and pulmonary embolism (PE).

    Tweet Tweets with this article
    • The Bristol Myers Squibb–Pfizer Alliance, with the support of leading advocacy organisations (such as AF Association) and medical societies, has launched a new US campaign — #NoTimeToWait — to raise awareness of #Afib, #DVT. and #PE https://t.co/rxkvjzXcOM https://t.co/D8odgN3CZL

  • Mashup Score: 3

    The Bristol Myers Squibb–Pfizer Alliance, with the support of leading advocacy organisations (such as AF Association) and medical societies, has launched a new US campaign — No Time To Wait — to raise awareness of three important conditions: Atrial Fibrillation (AF), deep vein thrombosis (DVT), and pulmonary embolism (PE).

    Tweet Tweets with this article
    • The Bristol Myers Squibb–Pfizer Alliance, with the support of leading advocacy organisations (such as @AtrialFibUK) and medical societies, has launched a new US campaign — #NoTimeToWait — to raise awareness of #Afib, #DVT. and #PE https://t.co/9x0Z7Krzlk https://t.co/iyhs7PSjW5